Bioquell An Ecolab Solution Bioquell An Ecolab Solution

52 Royce Close
West Portway
SP10 3TS
United Kingdom

+44 1264 835 835



Bioquell, an Ecolab solution, is a well-established global leader in the design and manufacture of high performance bio-decontamination solutions for risk reduction within the healthcare, life science and pharmaceutical industries. The UK-based company operates worldwide through its own sales offices and international distributor network.


Bioquell's validated and compliant Hydrogen Peroxide Vapour technology is used across the world to eradicate airborne biological contaminants including problematic bacteria, viruses and fungi on every exposed surface in any suitable enclosure to ensure maximum uptime. Deployment of Bioquell's Hydrogen Peroxide Vapour process provides residue-free, safe and repeatable disinfection of rooms, buildings, equipment and sensitive electronics. By eliminating 99.9999% of pathogens for a 6-log kill, it is a clear alternative to traditional methods such as formaldehyde or chlorine-based products.

Bioquell’s Hydrogen Peroxide Vapour, range of scalable systems, high quality consumables and expert services enable companies to work more productivity, manage risks to patients or workspaces and reduce operating costs.

Bioquell An Ecolab Solution

Life Sciences

Bioquell specialises in the design, manufacture and application of complete decontamination solutions for airborne and surface contamination in cGMP and cGLP environments. We have been operating in the life sciences industry for many years to become a premier provider of life science hydrogen peroxide vapour (HPV) bio-decontamination products and services as well as consultancy.

Discover a safer, more effective way to work by using Bioquell’s tailored solutions and personalised support for biodecontamination.

Video Bioquell Qube


Our Healthcare HPV decontamination technology is ideally suited for use in healthcare facilities due to its rapid, flexible and ‘residue-free’ nature. HPV has extensive, proven biological efficacy against a wide range of environmentally associated nosocomial pathogens, including Methicillin-resistant Staphylococcus aureus(MRSA), Clostridium difficile, Vancomycin-resistant enterococci (VRE), Klebsiella, Acinetobacter and other problematic Gram-negatives.

Video Bioquell BQ50